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a
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Abstract. The aim was to explore user experiences of using a telehealth system 
(Telekit) designed for the Danish TeleCare North trial. Telekit is designed for 
patients diagnosed with chronic obstructive pulmonary disease (COPD) in order to 
manage the disease and support patient empowerment. This article sums up 
COPD-participants’ user experiences in terms of increased sense of freedom, of 
security, of control, and greater awareness of COPD symptoms. A consecutive 
sample of sixty participants (27 women, 33 men) were recruited from the TeleCare 
North trial. At home the participants completed a non-standardised questionnaire 
while a researcher was present. The questionnaire identified their health status, 
their use of specific technologies, and their user experiences with the telehealth 
system. Results from the questionnaire indicate that the majority of participants 
(88%) considered the Telekit system as easy to use. 43 (72%) participants felt 
increased sense of security, and 37 (62%) participants felt increased sense of 
control by using the system. 30 (50%) participants felt greater awareness of their 
COPD symptoms, but only 16 (27%) participants felt increased freedom. The 
study has provided a general picture of COPD participants’ user experiences which 
is important to emphasise as it has a bearing on whether a given implementation 
will be successful or not. 
Keywords. Handheld computers, questionnaires, quality improvement, chronic 
obstructive pulmonary disease, telemedicine, patient satisfaction 
Introduction 
Chronic obstructive pulmonary disease (COPD) places a huge burden on healthcare 
and the health of patients. The disease is a leading cause of dead worldwide and has 
significant impact on disability, quality of life and costs. The burden of COPD is 
intended to increase in the coming decades due to continued exposure to risk factors 
and the changing age structure of the world’s population. COPD is a challenge for the 
health system, and we must transform the management of the disease by developing 
and implementing new and innovative treatment methods [1,2].   
Telehealth can deliver a range of clinical services and shows promise for 
supporting patients in managing their chronic conditions, such as COPD. Telehealth 
has the potential to improve chronic disease outcomes, increase empowerment and 
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reduce mortality- and admissions rates [3]. There is evidence that people are generally 
positive towards telehealth, and this evidence is important for having the opportunity to 
modify the telehealth systems to the patients’ needs [4]. However, this evidence is 
rather unclear which argues for more robust studies of specific population groups [5]. 
As telehealth systems may present challenges, especially for elderly people, it is 
paramount to explore their use of and experiences with such systems. Many people, 
including elderly, may be resistant to change due to limited cognitive and physical 
capabilities. These limited capabilities can affect the interaction between the individual 
and the telehealth system and reduce the efficacy of telehealth systems [6].  
A large-scale, pragmatic, cluster randomised Danish trial (TeleCare North) with 
12-month follow up will be implemented from 2014 to 2015. The trial will provide 
evidence of the economic and health- and patient-related effects of telehealth. TeleCare 
North has designed a telehealth system (Telekit) targeted all COPD patients in the 
North Denmark Region with the aim of empowering patients to retake more charge and 
responsibility for their own lives. 1,225 patients are enrolled in the trial and half of 
them have received the Telekit system, and use it at home to help with the management 
of their disease [7].  
In two previous usability studies, a heuristic evaluation and a think aloud test were 
performed on the Telekit system. Usability issues were identified through these studies, 
and this has resulted in several significant changes and updated versions of the 
telehealth system [8,9].  
In this present study, we developed a questionnaire to explore participants’ user 
experiences with the Telekit system in terms of increased sense of freedom, of control, 
of security and greater awareness of symptoms. Such research is important before a 
potential widespread implementation can take place throughout Denmark. 
1. Methods 
1.1. Participants 
60 (27 women, 33 men) participants were recruited from a sample of the intervention 
group of the TeleCare North trial [7]. Participants were selected in a consecutive 
manner following the randomisation. The mean age was 70 (min 54, max 88) years 
(see Table 1). The participants had received the Telekit system including instruction in 
the use of the system two months earlier before data for this study were collected. The 
instruction from the TeleCare North trial consisted of two appointments with their 
healthcare provider or in groups at a health center.  
1.2. The Telekit system 
The Telekit system is a tablet (Samsung Galaxy TAB 2, 10.1, Samsung Electronics, 
Seoul, South Korea) containing information on how to manage COPD in general and 
software that automatically guides the patient in coping with their disease. The Telekit 
system can also wirelessly transmit disease specific data (blood pressure, pulse, oxygen 
saturation, and weight) using a fingertip pulse oximeter (Nonin, Onyx II% SpO2, A&D 
Medical, Tokyo, Japan), a blood pressure monitor (Model UA-767, plus BT-C, Nonin 
Medical, Minnesota, US), and a precision health scale (UC-321PBT-C, A&D Medical, 
Tokyo, Japan). The COPD patients respond to precoded disease specific questions 
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through the Telekit system. They also perform daily measurements of their vital signs 
the first two weeks and then one to two times per week. Patients are monitored 
asynchronously by a healthcare provider which also responds and contacts the patients 
whose vital signs deviate from expected values [7,10].  
1.3.   Study design and data collection 
Data collection for this study took place in the participants’ homes, where they 
completed a non-standardised questionnaire consisting of 14 questions. The 
questionnaire was developed to explore participants’ user experiences with the Telekit 
system and was in three parts; 1) seven questions about their health status/patient 
characteristics, 2) two questions about their use of specific technologies (computer, 
mobile phone, smartphone, and tablet), and 3) five questions referred to participants’ 
user experiences with the telehealth system. The last five questions about user 
experiences were coded as categorical variables with three categories: 1) How do you 
think the Telekit system is to use? (easy to use, fairly easy to use, difficult to use), 2-4) 
Do you feel increased sense of control, of freedom, and of security by using Telekit? 
(yes, no, do not know), and 5) Do you have greater awareness of your COPD 
symptoms by using Telekit? (yes, no, do not know).  
A researcher was present during the completion of each questionnaire to help 
participants with any comprehension issues. Data from the questionnaire were 
quantified, analysed and presented in terms of frequency, mean or percent using 
software SPSS Statistics, version 22.  
2. Results 
2.1. Participants’ characteristics 
The majority of participants (83%) were familiar with the specific technologies and 
used more than one of these technologies: computer, mobile phone, smartphone or 
tablet for sending/receiving emails, searching information, paying bills, reading news, 
sending SMS/MMS, and making phone calls. The largest number of participants were 
skilled trained (45%) or had an elementary school education (35%). More than half 
(55%) were not able to classify their disease severity into mild, moderate, severe or 
very severe stage. The participants who knew their disease severity classified 
themselves mostly within the stages moderate (15%) to severe (18%) COPD. About 
half of the participants scored a Medical Research Council (MRC) score 2 and 3 (53%), 
where the score is the degree of a patient’s breathlessness [11] (see Table 1).   
 
Table 1: Participants' characteristics. 
Descriptive characteristics n (%) or mean (range) 
Female, n (%) 
Male, n (%) 
Age, mean (min, max) 
27 (45%) 
33 (55%) 
70.10 (54, 88) 
Highest education, n (%)  
Elementary school (9th or 10th grade) or less 
High school 
Higher education  
Skilled worker – craft, industry etc. 
21 (35%) 
4 (7%) 
8 (13%) 
27 (45%) 
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Severity of COPD, n (%)  
Mild 
Moderate 
Severe 
Very severe 
Do not know 
5 (8%) 
9 (15%) 
11 (18%) 
2 (3%) 
33 (55%) 
MRC dyspnoea classification, n (%)  
MRC 1 
MRC 2 
MRC 3 
MRC 4 
MRC 5 
9 (15%) 
20 (33%) 
12 (20%) 
10 (17%) 
7 (12%) 
Use of specific technologies (computer, tablet etc.), n/(%)  
One 
More than one  
None 
50 (83%) 
9 (15%) 
1 (2%) 
 
2.2. Participants’ user experience of the Telekit system 
53 (88%) of the participants considered the Telekit system as easy to use. Five (8%) 
participants agreed that the system was fairly easy to use, and the last two (3%) 
perceived the Telekit system as difficult to use. The majority of the participants 
responded that they experienced increased sense of control (62%) and of security 
(72%) by using the Telekit system. Half om the participants (50%) experienced also a 
greater awareness of their COPD symptoms, but only 16 (27%) responded positive 
about feeling increased sense of freedom (see Table 2). 
 
Table 2: Participants’ answers to their user experiences with the Telekit system. 
 Increasedcontrol
n/(%)
Increased
securityn/(%)
Increased
freedomn/(%)
Greaterawarenessof
symptomsn/(%)
Yes 37 (61.7) 43 (71.7) 16 (26.7) 30 (50) 
No 21 (35) 11 (18.3) 37 (61.7) 25 (41.7) 
Do not know 2 (3.3) 6 (10) 7 (11.7) 5 (8.3) 
Total (n) 60 60 60 60 
3. Discussion 
A systematic review clarifies that telehealth interventions still need to be adjusted to 
the target population by assessing patient characteristics, user experiences and 
acceptance of telehealth systems [4]. In spite of the considerable quantity of telehealth 
satisfaction and user experience studies available in the literature, we do not believe 
that it makes sense to transfer the results obtained by these studies to our study.  
This study explored the participants’ user experiences with the Telekit system from 
the Danish TeleCare North trial. Results demonstrate that the majority of the 
participants (88%) considered the Telekit system as easy to use. The participants 
experienced increased sense of control, of security, and greater awareness of COPD 
symptoms by using the Telekit system. In contrast the participants’ responses to 
whether they felt increased freedom  by using the Telekit system were less convincing. 
Previous studies have also evaluated the use of the Telekit system in terms of 
usability and satisfaction. Findings from these two studies reinforce our results because 
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they confirm that the participants are positive and satisfied with the Telekit system and 
nearly all participants (both usability experts and COPD patients) perceive the 
functionalities in Telekit as easy to use [8,9].  
This study had some strengths and limitations. One strength is that the study took 
place in the participants’ own homes, which provided a more comfortable enviroment 
and lessened the stressful situation for the participants. This may have increased the 
quality of the questionnaire responds. Another strength may be that we used a paper-
based questionnaire, which can be an advantage for especially COPD patients who 
might need to make a great cognitive effort in filling out the questionnaire. 
Furthermore, lack of understanding questions could be a problem, but this was 
prevented by the researcher’s presence to clarify problems. The researcher’s presence 
also ensured a high response rate. 
A limitation of this study was the relatively small sample size (n=60) which may 
limit the generalisability of our results. Future research should include more 
participants from the intervention group of the TeleCare North trial. In addition, studies 
should also include other disease groups as little is known whether these results can be 
generalised to other diseases. Furthermore, this study was also limited in the fact that 
the participants had used the Telekit system for only two months, and their user 
experiences can change as they become more familiar with the system. Future research 
should explore the participant’ user experiences when they have used the Telekit 
system for a longer period.  
In conclusion, this article has generated knowledge regarding the participants’ user 
experiences with the Telekit system. This knowledge is essential in order to determine 
whether the system will be implemented to other parts of Denmark. We recommend to 
explore users’ experiences when new telehealth systems are developed and before 
widespread implementations, as it has huge influence on the outcomes of these 
implementations.  
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